Registro Completo |
Biblioteca(s): |
Ebooks. |
Data corrente: |
01/02/2013 |
Data da última atualização: |
04/02/2013 |
Autoria: |
REHBINDER, E.; REHBINDER, E.; ENGELHARD, M.; HAGEN, K.; JØRGENSEN, R. B.; PARDO-AVELLANEDA, R.; SCHNIEKE, A.; THIELE, F. |
Afiliação: |
Eckard Rehbinder; E. Rehbinder; M. Engelhard; K. Hagen; R. B. Jørgensen; R. Pardo-avellaneda; A. Schnieke; F. Thiele. |
Título: |
Pharming: Promises and risks of biopharmaceuticals derived from genetically modified plants and animals. |
Ano de publicação: |
2009 |
Fonte/Imprenta: |
Springer eBooks. |
Volume: |
35 |
Descrição Física: |
digital. |
Série: |
Ethics of Science and Technology Assessment, Schriftenreihe der Europäischen Akademie zur Erforschung von Folgen wissenschaftlich-technisch |
ISBN: |
9783540857938 |
DOI: |
10.1007/978-3-540-85793-8 |
Idioma: |
Inglês |
Conteúdo: |
Introduction -- The Technology of Pharming -- Risk Assessment of Plant- and Animal Pharming -- The Welfare of Pharming Animals -- Public Views and Attitudes to Pharming -- The Ethical Evaluation of Pharming -- The Role of Patents in the Development of Pharming -- Legal Problems of Pharming -- Conclusions and Recommendations. .Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed. The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks related to pharming and welfare risks for pharming animals. Public views and attitudes to pharming are investigated on the basis of a comprehensive survey in 15 countries. Moreover, ethical and legal questions, posed by present and foreseeable future practices of pharming, are analysed. The concluding chapter presents the authors’ main findings and recommendations, addressed to science, industry, politics and general public interested in the chances and risks of this upcoming field of biotechnology. MenosIntroduction -- The Technology of Pharming -- Risk Assessment of Plant- and Animal Pharming -- The Welfare of Pharming Animals -- Public Views and Attitudes to Pharming -- The Ethical Evaluation of Pharming -- The Role of Patents in the Development of Pharming -- Legal Problems of Pharming -- Conclusions and Recommendations. .Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed. The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks re... Mostrar Tudo |
Palavras-Chave: |
Biochemical Engineering; Biomedical Engineering; Biomedicine; Pharmacology/Toxicology. |
Thesaurus Nal: |
ethics; medicine; toxicology. |
Categoria do assunto: |
-- |
URL: |
https://dx.doi.org/10.1007/978-3-540-85793-8
|
Marc: |
LEADER 03093nam a2200325 a 4500 001 1947474 005 2013-02-04 008 2009 bl uuuu 00u1 u #d 020 $a9783540857938 024 7 $a10.1007/978-3-540-85793-8$2DOI 100 1 $aREHBINDER, E. 245 $aPharming$bPromises and risks of biopharmaceuticals derived from genetically modified plants and animals.$h[electronic resource] 260 $aSpringer eBooks.$c2009 300 $a35$cdigital. 490 $aEthics of Science and Technology Assessment, Schriftenreihe der Europäischen Akademie zur Erforschung von Folgen wissenschaftlich-technisch$v35 520 $a<P>Introduction -- The Technology of Pharming -- Risk Assessment of Plant- and Animal Pharming -- The Welfare of Pharming Animals -- Public Views and Attitudes to Pharming -- The Ethical Evaluation of Pharming -- The Role of Patents in the Development of Pharming -- Legal Problems of Pharming -- Conclusions and Recommendations.</P>.<P>Recent scientific advances have made it possible to produce biopharmaceuticals in genetically modified plants and animals, such as maize, tobacco, goats, and chickens. This new branch of biotechnology is termed pharming, composed of the terms pharmaceuticals and farming. Pharming constitutes an overlap of red and green biotechnology. It offers the prospect of a quicker, cheaper, and more flexible production of biopharmaceuticals compared with current production processes. This is a promising perspective in light of the rapidly growing market of biopharmaceuticals, although the economic competitiveness of pharming remains to be proven. Besides possible benefits for producers, patients and health care systems, pharming also raises a number of complex ecological, social, moral and legal questions that have as yet not been thoroughly discussed. </P> <P></P> <P>The present book contains the findings of an interdisciplinary research project that has addressed a large range of questions associated with pharming: An analysis of the state-of-the-art of plant pharming and animal pharming technologies is followed by an assessment of environmental risks related to pharming and welfare risks for pharming animals. Public views and attitudes to pharming are investigated on the basis of a comprehensive survey in 15 countries. Moreover, ethical and legal questions, posed by present and foreseeable future practices of pharming, are analysed. The concluding chapter presents the authors’ main findings and recommendations, addressed to science, industry, politics and general public interested in the chances and risks of this upcoming field of biotechnology.</P> 650 $aethics 650 $amedicine 650 $atoxicology 653 $aBiochemical Engineering 653 $aBiomedical Engineering 653 $aBiomedicine 653 $aPharmacology/Toxicology 700 1 $aREHBINDER, E. 700 1 $aENGELHARD, M. 700 1 $aHAGEN, K. 700 1 $aJØRGENSEN, R. B. 700 1 $aPARDO-AVELLANEDA, R. 700 1 $aSCHNIEKE, A. 700 1 $aTHIELE, F.
Download
Esconder MarcMostrar Marc Completo |
Registro original: |
Ebooks (Ebooks) |
|